▁Chron 10.375
ic 5.49609375
▁pain 11.6953125
▁is 5.5546875
▁still 6.25390625
▁considered 5.03125
▁to 1.7314453125
▁be 0.4521484375
▁an 3.0078125
▁extreme 5.94921875
▁issue 7.3828125
▁among 7.328125
▁at 6.82421875
▁least 1.4091796875
▁ 2.65234375
8 3.197265625
% 4.31640625
▁of 1.8486328125
▁the 1.236328125
▁residents 6.89453125
▁of 2.294921875
▁progress 9.4140625
ive 0.9912109375
▁countries 6.890625
. 2.107421875
▁The 2.505859375
▁introduction 7.234375
▁of 0.257568359375
▁the 1.609375
▁study 6.78515625
▁describes 8.03125
▁the 0.865234375
▁apparent 9.0703125
▁link 6.33203125
▁between 0.5322265625
▁pain 6.2734375
▁and 0.7470703125
▁dem 8.3671875
oral 3.49609375
ization 0.281982421875
. 1.4599609375
▁Chron 6.23046875
ic 0.0287628173828125
▁pain 0.312255859375
▁is 1.30078125
▁always 6.3828125
▁accompanied 2.1875
▁by 0.05865478515625
▁negative 4.90234375
▁emot 1.482421875
ional 1.314453125
▁experiences 2.96875
▁and 2.12109375
▁blocks 11.046875
▁a 4.15234375
▁person 1.4033203125
’ 24.859375
s 1.9921875
▁ability 1.8544921875
▁to 0.047698974609375
▁receive 6.296875
▁joy 4.91796875
▁and 1.3935546875
▁satisfaction 3.03125
▁from 1.216796875
▁life 1.033203125
. 0.3251953125
▁The 1.890625
▁research 3.916015625
▁investig 5.296875
ates 0.46044921875
▁the 0.483154296875
▁development 5.9140625
▁of 0.1756591796875
▁de 3.84375
pression 0.254638671875
▁and 1.2861328125
▁anx 2.255859375
iety 0.004974365234375
▁among 2.369140625
▁patients 2.458984375
▁receiving 4.5
▁ph 6.625
arma 1.783203125
ce 0.00861358642578125
ut 0.00045871734619140625
ical 0.0106964111328125
▁op 5.04296875
io 0.1884765625
ids 0.6259765625
▁and 2.384765625
▁medical 6.171875
▁mar 1.498046875
iju 0.048919677734375
ana 0.00020039081573486328
▁( 4.390625
MM 0.68310546875
) 3.458984375
▁As 9.15625
▁severe 9.578125
▁pain 1.5400390625
kill 5.0234375
ers 0.006061553955078125
. 2.751953125
▁it 8.1328125
▁comp 8.484375
ares 0.1766357421875
▁the 0.736328125
▁effic 6.06640625
acy 0.0110626220703125
▁of 0.326904296875
▁pres 5.0234375
cri 1.8271484375
ptions 0.62841796875
▁and 2.267578125
▁exam 6.7421875
ines 0.0187835693359375
▁the 0.458740234375
▁possibility 3.994140625
▁of 0.11590576171875
▁post 7.01953125
- 0.6162109375
tre 2.58203125
at 0.01934814453125
ment 0.00894927978515625
▁de 1.6884765625
pression 0.0982666015625
. 1.5537109375
<0x0A> 2.126953125
There 4.703125
▁is 1.0556640625
▁currently 4.421875
▁a 1.318359375
▁severe 4.9140625
▁lack 3.291015625
▁of 0.028076171875
▁information 2.111328125
▁about 1.451171875
▁the 0.48486328125
▁effects 2.7578125
▁of 0.0731201171875
▁op 1.7998046875
i 4.03125
ates 0.11871337890625
. 3.765625
▁They 5.03125
▁manage 8.71875
▁pain 3.2421875
▁successfully 5.88671875
, 1.1552734375
▁but 0.368896484375
▁the 2.6953125
▁past 9.265625
▁few 2.396484375
▁dec 0.87255859375
ades 8.702278137207031e-05
▁indicated 9.7265625
▁the 2.171875
▁growing 4.65234375
▁concern 3.513671875
▁regarding 3.029296875
▁op 3.298828125
iate 0.75
▁ab 1.537109375
use 0.0081939697265625
▁in 3.38671875
▁forms 10.6328125
▁of 0.49755859375
▁over 3.521484375
d 0.369384765625
ose 0.1544189453125
▁and 0.70849609375
▁add 1.17578125
iction 0.0283050537109375
. 0.2410888671875
▁A 4.0703125
▁more 5.78515625
▁manage 8.765625
able 0.0048675537109375
▁and 2.22265625
▁sa 2.404296875
fer 0.0001214742660522461
▁alternative 1.685546875
▁might 6.20703125
▁be 0.2061767578125
▁medical 2.783203125
▁mar 0.1905517578125
iju 0.004322052001953125
ana 0.0008463859558105469
. 1.5537109375
▁However 3.205078125
, 0.01250457763671875
▁the 1.6533203125
▁legal 4.52734375
▁status 1.1806640625
▁and 2.7578125
▁novel 9.203125
ty 0.6943359375
▁of 0.207763671875
▁this 1.6533203125
▁drug 2.05859375
▁do 5.2421875
▁not 0.08172607421875
▁allow 1.064453125
▁finding 9.0390625
▁a 2.23828125
▁large 4.2265625
▁number 1.4462890625
▁of 0.005916595458984375
▁studies 1.287109375
▁on 1.5185546875
▁its 1.091796875
▁effect 2.03515625
iveness 0.469482421875
. 0.9921875
▁Specifically 7.91015625
, 0.11676025390625
▁it 2.75
▁concerns 4.77734375
▁the 0.57958984375
▁emot 7.375
ional 0.01568603515625
▁condition 5.296875
▁of 0.33935546875
▁patients 0.6904296875
▁experien 6.5
cing 4.506111145019531e-05
▁chron 1.0751953125
ic 0.002223968505859375
▁pain 0.10687255859375
. 0.73681640625
▁This 3.123046875
▁research 3.009765625
▁paper 6.234375
▁a 2.275390625
ims 0.0004801750183105469
▁to 0.06982421875
▁analyze 3.01953125
▁levels 9.7421875
▁of 0.036773681640625
▁de 0.57421875
pression 0.03662109375
▁and 0.273681640625
▁anx 0.046112060546875
iety 0.0011997222900390625
▁among 0.7890625
▁people 3.291015625
▁receiving 0.9130859375
▁ther 7.65625
apy 0.3212890625
▁by 5.28125
▁comparing 7.8671875
▁the 0.908203125
▁effects 2.072265625
▁of 0.027679443359375
▁ph 2.669921875
arma 0.044281005859375
ce 0.001346588134765625
ut 6.175041198730469e-05
ical 0.0030059814453125
▁op 0.34423828125
io 0.1649169921875
ids 0.061431884765625
▁an 10.0234375
D 9.0234375
▁MM 2.302734375
. 0.6513671875
<0x0A> 0.97509765625
The 1.37890625
▁study 2.03515625
▁was 2.044921875
▁conducted 0.7470703125
▁in 1.541015625
▁the 1.3642578125
▁form 2.47265625
▁of 0.01116180419921875
▁collection 10.15625
▁and 1.625
▁analysis 0.72021484375
▁of 0.057098388671875
▁statistical 4.11328125
▁data 0.1304931640625
. 0.96728515625
▁Part 4.97265625
icip 0.0611572265625
ants 0.050537109375
▁were 0.76611328125
▁rec 3.259765625
ru 0.0014047622680664062
ited 8.821487426757812e-05
▁for 3.955078125
▁six 7.5546875
▁months 0.472412109375
▁at 3.8125
▁two 2.669921875
▁major 5.4296875
▁pain 3.642578125
▁relief 5.36328125
▁cent 1.4658203125
ers 0.061248779296875
▁in 0.7373046875
▁Israel 4.23828125
. 0.447998046875
▁The 1.20703125
▁research 2.296875
ers 1.44921875
▁used 2.685546875
▁The 7.7890625
▁De 4.375
pression 0.01473236083984375
▁Module 9.921875
▁of 0.99755859375
▁the 0.320068359375
▁Pat 2.40625
ient 0.00873565673828125
▁Health 0.09185791015625
▁Question 0.019012451171875
naire 0.0215606689453125
▁and 3.4453125
▁the 0.6728515625
▁General 1.7109375
ized 0.72802734375
▁An 0.0200958251953125
x 0.00025153160095214844
iety 0.0036945343017578125
▁Dis 0.51171875
order 0.037445068359375
▁Sc 1.255859375
ale 0.08135986328125
▁to 1.8447265625
▁interview 7.07421875
▁participants 2.064453125
, 3.61328125
▁evaluate 5.60546875
▁their 0.77197265625
▁answers 6.44921875
, 1.013671875
▁and 0.1636962890625
▁conduct 4.5390625
▁the 2.390625
▁study 2.12890625
. 0.24169921875
▁To 4.984375
▁specifically 10.0546875
▁evaluate 2.51953125
▁and 4.31640625
▁compare 1.0615234375
▁the 0.336669921875
▁prob 11.125
abilities 0.193359375
▁of 0.131591796875
▁de 0.8134765625
pression 0.040008544921875
▁or 4.70703125
▁anx 0.044891357421875
iety 0.0004591941833496094
▁among 1.6025390625
▁the 2.3359375
▁diverse 8.921875
▁groups 1.6015625
, 1.5986328125
▁the 1.0390625
▁study 2.625
▁used 1.623046875
▁multiple 4.71875
▁log 2.9609375
istic 0.041229248046875
▁regression 0.09161376953125
▁analysis 0.662109375
▁and 2.537109375
▁chose 8.9609375
▁medical 7.5234375
▁mar 0.358154296875
iju 0.00333404541015625
ana 0.0009121894836425781
▁as 0.9794921875
▁the 1.072265625
▁control 2.40234375
▁group 0.556640625
. 0.300048828125
<0x0A> 0.76220703125
This 3.390625
▁type 6.1328125
▁of 0.00919342041015625
▁study 1.6513671875
▁is 1.232421875
▁the 3.396484375
▁most 1.8095703125
▁reve 9.359375
aling 0.0008711814880371094
▁and 1.0322265625
▁inclus 6.51953125
ive 0.0025348663330078125
, 2.22265625
▁as 1.958984375
▁it 0.350341796875
▁contains 4.91015625
▁direct 6.38671875
▁responses 5.046875
▁from 0.8427734375
▁a 3.8046875
▁large 0.87158203125
▁number 0.4287109375
▁of 0.0037517547607421875
▁participants 1.515625
. 0.705078125
▁All 4.71484375
▁tools 9.0703125
▁in 4.48828125
▁the 0.7177734375
▁form 3.4921875
▁of 0.04486083984375
▁question 1.8818359375
na 0.04254150390625
ires 0.00012183189392089844
▁and 2.083984375
▁scales 3.048828125
▁have 3.533203125
▁already 4.48828125
▁been 0.1729736328125
▁used 2.00390625
▁and 2.087890625
▁proved 4.3203125
▁their 1.8212890625
▁effic 4.0703125
acy 7.808208465576172e-05
▁for 3.62890625
▁collect 4.54296875
ing 0.017791748046875
▁analyt 8.25
ical 0.2264404296875
▁data 0.285888671875
. 0.45263671875
▁It 3.65234375
▁helps 4.95703125
▁to 0.94140625
▁system 7.44140625
at 1.357421875
ize 0.00673675537109375
▁and 1.5791015625
▁class 3.986328125
ify 0.0024127960205078125
▁distinct 9.375
▁kinds 6.3359375
▁of 0.0287017822265625
▁information 3.39453125
▁for 3.865234375
▁subsequent 3.953125
▁un 8.078125
comp 5.48046875
licated 0.06390380859375
▁services 11.65625
. 0.638671875
▁Thus 4.41015625
, 0.027984619140625
▁research 4.5
ers 0.5771484375
▁can 1.345703125
▁compare 3.984375
▁the 0.93115234375
▁effects 3.021484375
▁of 0.103271484375
▁medic 4.38671875
ations 0.88232421875
▁on 1.7275390625
▁patients 2.1015625
▁of 4.53515625
▁diverse 4.23046875
▁age 2.892578125
▁groups 0.64501953125
, 0.9365234375
▁background 5.08203125
s 0.2138671875
, 0.0914306640625
▁physical 5.32421875
▁conditions 1.458984375
, 0.1099853515625
▁emot 5.54296875
ional 0.059844970703125
▁states 1.41015625
, 0.1331787109375
▁and 0.45751953125
▁so 3.177734375
▁on 0.31103515625
. 0.1103515625
<0x0A> 0.68017578125
The 1.119140625
▁analysis 4.58203125
▁of 0.5546875
▁any 8.921875
▁human 6.15625
▁reaction 4.97265625
▁has 4.5859375
▁a 1.71875
▁high 4.4453125
▁potential 3.587890625
▁of 1.693359375
▁subject 5.9921875
iveness 3.958984375
▁and 1.3486328125
▁bias 2.26171875
, 1.83203125
▁especially 2.48828125
▁regarding 4.5859375
▁people 4.4765625
▁in 3.943359375
▁severe 4.484375
▁pain 0.296142578125
▁and 2.666015625
▁un 5.328125
stable 1.828125
▁emot 0.8515625
ional 0.1700439453125
▁condition 2.728515625
. 0.08709716796875
▁Perhaps 8.859375
▁some 4.8359375
▁patients 2.287109375
▁tend 5.42578125
▁to 0.0200958251953125
▁ex 2.58203125
agger 0.0015306472778320312
ate 0.006076812744140625
▁their 0.7421875
▁de 5.203125
press 1.3564453125
ive 0.2452392578125
▁state 3.056640625
▁or 1.8759765625
▁vice 7.34375
▁vers 0.01554107666015625
a 0.00010561943054199219
, 1.0107421875
▁de 7.2734375
- 4.953125
emph 1.001953125
as 0.0062255859375
ize 0.1258544921875
▁serious 6.63671875
▁difficulties 5.90234375
. 0.865234375
▁Because 6.06640625
▁the 2.216796875
▁survey 6.05859375
▁responses 6.6796875
▁were 1.6298828125
▁thoroughly 7.92578125
▁anonymous 5.35546875
, 0.48095703125
▁the 1.46484375
▁research 1.58203125
ers 0.294677734375
▁were 1.4306640625
▁unable 2.3515625
▁to 0.0036830902099609375
▁carefully 8.75
▁analyze 1.6328125
▁each 3.9609375
▁patient 2.435546875
’ 27.03125
s 0.91357421875
▁reaction 3.658203125
▁and 2.3671875
▁compare 3.4921875
▁it 0.912109375
▁to 1.263671875
▁the 0.7490234375
▁actual 5.69140625
▁states 7.328125
▁of 0.6689453125
▁condition 7.296875
. 0.392333984375
▁More 6.8984375
▁accurate 3.779296875
▁answers 4.65625
▁could 2.544921875
▁be 0.88525390625
▁obtained 0.9638671875
▁by 1.375
▁professional 7.51953125
▁psych 2.185546875
olog 0.333251953125
ists 0.001270294189453125
▁via 7.9921875
▁personal 3.921875
▁communication 4.58984375
▁and 1.8623046875
▁behavior 7.17578125
al 0.351318359375
▁analysis 2.291015625
. 0.238037109375
▁However 2.833984375
, 0.003612518310546875
▁this 1.9091796875
▁method 2.87109375
▁of 2.263671875
▁research 2.142578125
▁is 0.92626953125
▁way 7.9453125
▁more 1.787109375
▁resource 6.5625
- 0.451171875
int 0.5087890625
ensive 0.00861358642578125
▁and 0.62060546875
▁energy 8.640625
- 0.11944580078125
consum 0.320556640625
ing 0.0019178390502929688
. 0.5966796875
<0x0A> 0.64892578125
Part 5.59375
icip 0.0859375
ants 0.1153564453125
▁were 1.005859375
▁rec 1.529296875
ru 0.001194000244140625
ited 0.0001062154769897461
▁for 1.12109375
▁six 1.193359375
▁months 0.0208892822265625
▁at 0.451904296875
▁two 0.112548828125
▁major 0.33984375
▁pain 0.036956787109375
▁relief 0.0322265625
▁cent 0.0325927734375
ers 0.00577545166015625
▁in 0.061553955078125
▁Israel 0.03363037109375
. 0.15673828125
▁All 3.48828125
▁patients 1.4755859375
▁experienced 5.7109375
▁chron 1.6416015625
ic 0.003055572509765625
▁pain 0.10235595703125
▁for 3.39453125
▁at 0.732421875
▁least 0.0010890960693359375
▁ 1.00390625
3 1.4609375
▁months 0.2119140625
. 1.0029296875
▁The 1.4658203125
▁study 1.908203125
▁included 2.15234375
▁ 1.1474609375
8 2.865234375
9 2.767578125
0 3.619140625
▁participants 1.54296875
, 1.236328125
▁of 1.7314453125
▁which 0.406494140625
▁ 0.147705078125
4 1.599609375
7 2.4765625
4 2.744140625
▁( 2.201171875
5 0.1055908203125
9 11.15625
%) 1.015625
▁were 0.489013671875
▁treated 4.43359375
▁sole 6.890625
ly 0.0001360177993774414
▁with 0.4521484375
▁op 0.8330078125
io 0.380615234375
ids 0.19189453125
, 1.18359375
▁ 0.60400390625
3 1.09765625
2 2.072265625
9 2.578125
▁( 0.058074951171875
4 1.19140625
1 1.23828125
%) 0.1331787109375
▁were 1.3203125
▁treated 0.479736328125
▁with 0.164306640625
▁MM 1.021484375
, 0.208740234375
▁and 0.14404296875
▁ 0.1419677734375
7 3.212890625
7 2.42578125
▁( 0.1815185546875
8 3.724609375
. 1.142578125
6 2.955078125
%) 0.058197021484375
▁acquired 9.875
▁both 1.1708984375
▁( 7.05078125
Fe 10.0
ing 3.2265625
old 0.022857666015625
▁et 1.40625
▁al 0.0254364013671875
., 0.359619140625
▁ 0.0148773193359375
2 0.1634521484375
0 0.000614166259765625
1 0.394287109375
7 2.0703125
). 0.1407470703125
▁The 1.357421875
▁remaining 7.01953125
▁ten 8.1015625
▁participants 1.3681640625
▁who 5.4765625
▁did 1.45703125
▁not 0.00647735595703125
▁receive 1.84375
▁ph 3.064453125
arma 0.06695556640625
ce 0.0015935897827148438
ut 2.658367156982422e-05
ical 0.0033435821533203125
▁op 1.0263671875
io 0.0784912109375
ids 0.0254364013671875
▁and 1.640625
▁medical 1.83984375
▁mar 0.043914794921875
iju 0.005764007568359375
ana 0.0001163482666015625
▁were 1.109375
▁with 5.953125
dra 0.135498046875
wn 0.00012791156768798828
▁from 0.26025390625
▁the 0.1123046875
▁analysis 4.65625
▁in 4.76171875
▁the 1.1796875
▁research 4.3203125
. 0.72314453125
▁Therefore 4.87109375
, 0.00923919677734375
▁it 3.916015625
▁is 1.068359375
▁not 2.7421875
▁possible 0.681640625
▁to 0.021484375
▁compreh 6.609375
ens 0.05340576171875
ively 0.009490966796875
▁compare 1.8662109375
▁patients 4.73828125
▁taking 4.29296875
▁medic 3.697265625
ations 0.49169921875
▁with 0.9912109375
▁those 1.1083984375
▁who 1.1298828125
▁do 1.7041015625
▁not 0.00849151611328125
. 0.810546875
<0x0A> 0.6240234375
The 1.1484375
▁study 1.677734375
▁conducted 4.8125
▁a 2.060546875
▁correlation 6.0
▁type 7.34375
▁of 0.46240234375
▁research 1.927734375
▁with 2.845703125
▁variable 8.1015625
▁measures 4.57421875
. 1.2451171875
▁It 2.3125
▁evaluated 4.5625
▁the 0.552734375
▁inter 6.3125
dep 3.62890625
end 0.0005803108215332031
ence 0.00970458984375
▁of 0.57666015625
▁various 3.921875
▁factors 1.6513671875
▁that 2.759765625
▁affected 4.1015625
▁the 0.5498046875
▁physical 6.87109375
▁and 0.908203125
▁emot 0.50390625
ional 0.00036787986755371094
▁condition 1.052734375
▁of 0.1036376953125
▁patients 0.5986328125
▁experien 4.1953125
cing 3.3855438232421875e-05
▁chron 0.52197265625
ic 0.0006403923034667969
▁pain 0.027130126953125
. 0.2110595703125
▁For 3.775390625
▁example 1.0517578125
, 0.0208740234375
▁the 1.2099609375
▁survey 5.12109375
▁showed 3.4140625
▁that 0.404296875
▁the 1.7080078125
▁ratio 7.05078125
▁of 0.1219482421875
▁female 4.50390625
▁patients 0.765625
▁was 1.8759765625
▁remark 9.6171875
ably 0.0005822181701660156
▁higher 0.51171875
▁in 2.685546875
▁the 0.896484375
▁op 4.48046875
i 4.03125
ates 0.10693359375
▁group 0.27001953125
▁compared 2.681640625
▁to 0.12890625
▁the 0.475830078125
▁MM 0.50341796875
▁group 0.27392578125
. 0.472900390625
▁In 2.896484375
▁turn 4.08203125
, 0.003803253173828125
▁people 6.01953125
▁on 5.40234375
▁op 1.3173828125
i 0.44482421875
ates 0.004001617431640625
▁were 1.0234375
▁more 1.0087890625
▁likely 0.370361328125
▁to 0.06298828125
▁report 3.14453125
▁major 5.95703125
▁de 0.400146484375
press 1.228515625
ive 0.00408935546875
▁dis 0.53857421875
orders 1.291015625
. 1.759765625
<0x0A> 2.537109375
The 1.1484375
▁question 5.68359375
na 1.3935546875
ires 9.071826934814453e-05
▁used 1.9765625
▁dif 17.109375
F 4.69140625
er 0.1397705078125
ent 0.6123046875
▁variable 8.140625
▁measures 0.7216796875
▁to 1.416015625
▁collect 2.46484375
▁information 2.037109375
. 1.732421875
▁For 1.9912109375
▁example 0.195068359375
, 0.01146697998046875
▁it 3.841796875
▁included 2.6328125
▁comp 10.2265625
re 4.39453125
hen 1.8544921875
S 1.458984375
ive 0.2239990234375
▁so 7.9453125
cio 0.389892578125
- 0.52880859375
dem 0.1331787109375
ographic 0.04400634765625
▁data 1.1845703125
: 4.5078125
▁gender 1.662109375
, 0.1090087890625
▁age 0.1962890625
, 0.09173583984375
▁country 4.36328125
, 1.4072265625
▁type 4.46484375
▁of 0.057830810546875
▁residence 4.0
▁( 3.373046875
urban 2.076171875
/ 2.892578125
r 0.0772705078125
ural 0.004100799560546875
), 0.244140625
▁years 5.9375
▁of 0.17138671875
▁education 0.783203125
, 0.1795654296875
▁and 1.7724609375
▁employ 3.68359375
ment 0.0117340087890625
▁status 0.417724609375
. 0.20556640625
▁Pat 4.19921875
ients 0.08551025390625
▁were 1.1533203125
▁also 0.88427734375
▁asked 0.57275390625
▁about 1.283203125
▁their 0.5810546875
▁medical 2.8203125
▁history 0.48095703125
▁over 8.8046875
▁the 0.1513671875
▁years 4.0
▁and 1.796875
▁the 1.8076171875
▁current 3.3828125
▁presence 5.75
▁of 0.060302734375
▁any 2.66796875
▁severe 4.8125
▁dise 1.55078125
ases 0.0007262229919433594
▁such 4.1171875
▁as 0.005313873291015625
▁heart 2.400390625
▁failure 2.013671875
, 0.2099609375
▁di 1.87890625
ab 0.00366973876953125
etes 0.0066986083984375
, 0.1392822265625
▁ar 3.802734375
th 0.126953125
rit 0.03643798828125
is 0.016357421875
, 0.052520751953125
▁and 1.55859375
▁so 0.7626953125
▁on 0.0328369140625
. 0.052581787109375
▁The 1.908203125
▁third 7.10546875
▁measure 4.140625
▁of 2.02734375
▁the 1.0341796875
▁question 2.783203125
naire 0.252197265625
▁was 1.0703125
▁indicated 9.71875
▁by 0.5986328125
▁information 6.39453125
▁on 1.505859375
▁any 5.38671875
▁twelve 13.734375
- 1.140625
month 0.3876953125
▁and 5.7890625
▁lifetime 3.201171875
▁drug 4.7890625
▁and 3.53515625
▁alco 0.08990478515625
hol 0.0006289482116699219
▁consumption 2.705078125
. 0.468505859375
▁In 3.40625
▁addition 0.77734375
, 0.1280517578125
▁the 1.1259765625
▁record 7.828125
▁included 1.6162109375
▁a 2.400390625
▁pain 6.71484375
▁measurement 4.296875
▁scale 0.98486328125
▁from 3.654296875
▁ 0.4384765625
0 0.44140625
▁to 0.450927734375
▁ 0.00843048095703125
1 0.094482421875
0 0.07501220703125
▁to 4.5625
▁evaluate 1.552734375
▁dis 6.08203125
com 0.17041015625
fort 0.0068817138671875
▁feelings 7.28515625
▁during 3.19921875
▁the 0.9013671875
▁last 1.4150390625
▁month 1.578125
. 0.27490234375
<0x0A> 1.080078125
Am 6.76171875
ong 0.01526641845703125
▁all 2.29296875
▁participants 2.017578125
▁in 3.466796875
▁the 0.1805419921875
▁study 0.3876953125
, 0.06195068359375
▁ 0.69921875
4 1.7607421875
2 2.748046875
. 1.83203125
2 2.296875
% 0.14306640625
▁suffered 4.8984375
▁from 0.132568359375
▁de 1.7705078125
pression 0.18505859375
, 1.080078125
▁and 1.7626953125
▁ 0.151123046875
3 1.7236328125
7 2.220703125
% 2.765625
▁experienced 2.29296875
▁excess 7.90234375
ive 0.11016845703125
▁anx 0.251953125
iety 0.002777099609375
. 0.337890625
▁The 1.435546875
▁pl 11.0859375
ur 1.0927734375
ality 0.00115966796875
▁of 0.1849365234375
▁de 3.578125
press 1.2705078125
ive 0.0245361328125
▁dis 1.7861328125
orders 0.057525634765625
▁among 3.798828125
▁patients 1.1650390625
▁in 3.6640625
▁the 0.347412109375
▁op 1.3505859375
i 0.9736328125
ates 0.006450653076171875
, 7.109375
▁medical 2.970703125
▁mar 0.022308349609375
iju 0.01186370849609375
ana 0.000225067138671875
, 0.141357421875
▁and 0.0631103515625
▁mixed 5.94921875
▁OP 8.6875
MM 5.84765625
▁groups 0.4580078125
▁number 8.078125
ed 0.014007568359375
▁ 0.1190185546875
5 2.154296875
7 2.482421875
. 0.2073974609375
1 2.369140625
%, 0.24560546875
▁ 0.00586700439453125
2 2.99609375
2 2.44140625
. 0.10784912109375
3 2.236328125
%, 0.12274169921875
▁and 0.031524658203125
▁ 0.0037860870361328125
5 3.216796875
1 2.595703125
. 0.1724853515625
4 2.150390625
%, 0.37158203125
▁respectively 0.01552581787109375
. 0.27392578125
▁The 1.4736328125
▁pl 4.5390625
ur 0.0221405029296875
ality 0.00011014938354492188
▁of 0.0380859375
▁anx 0.97265625
iety 0.01560211181640625
▁contained 11.0546875
▁ 0.68408203125
4 1.58203125
8 2.376953125
. 0.06304931640625
4 2.3046875
% 0.5283203125
▁among 1.478515625
▁OP 6.46875
▁patients 8.859375
, 0.28271484375
▁ 0.10284423828125
2 1.5029296875
1 2.416015625
. 0.1300048828125
5 2.4296875
% 0.0118865966796875
▁among 0.443115234375
▁MM 0.395751953125
▁patients 0.25341796875
, 0.01410675048828125
▁and 0.01419830322265625
▁ 0.042694091796875
3 1.234375
8 2.640625
. 0.1519775390625
7 2.28515625
% 0.014434814453125
▁among 0.2440185546875
▁OP 3.951171875
MM 0.23583984375
▁participants 3.552734375
. 0.231689453125
▁Pat 5.7421875
ients 0.0198211669921875
▁who 2.396484375
▁took 2.87890625
▁strong 8.1640625
▁op 1.111328125
i 1.384765625
ates 0.0049285888671875
▁were 1.7353515625
▁t 8.65625
ended 1.3818359375
▁to 0.016265869140625
▁place 10.34375
▁their 3.69921875
▁pain 2.6484375
▁on 3.470703125
▁a 0.8125
▁scale 2.326171875
▁of 0.6318359375
▁ 0.317626953125
9 2.8359375
▁to 1.3154296875
▁ 0.01488494873046875
1 0.023284912109375
0 0.09051513671875
▁( 2.6328125
Fe 1.669921875
ing 0.011962890625
old 0.0016565322875976562
▁et 0.0298309326171875
▁al 0.001903533935546875
., 0.00875091552734375
▁ 0.0027027130126953125
2 0.000652313232421875
0 7.176399230957031e-05
1 0.0021266937255859375
7 0.01491546630859375
). 0.05218505859375
▁They 4.76953125
▁were 1.3017578125
▁also 1.37890625
▁an 8.7109375
gu 4.29296875
ished 0.053955078125
▁em 8.515625
otion 0.0284881591796875
ally 0.005825042724609375
▁and 1.1416015625
▁react 6.85546875
ed 0.051910400390625
▁rad 9.484375
ically 0.0229339599609375
▁neg 5.15234375
atively 0.00208282470703125
▁to 0.339111328125
▁almost 5.19921875
▁all 1.1904296875
▁survey 8.125
▁questions 0.626953125
. 0.286376953125
▁Pat 4.22265625
ients 0.00745391845703125
▁who 1.1533203125
▁took 1.478515625
▁only 5.4140625
▁MM 0.9609375
▁or 3.244140625
▁mixed 3.111328125
▁medic 2.708984375
ations 0.324951171875
▁course 12.6484375
▁had 2.486328125
▁a 1.2275390625
▁significantly 2.525390625
▁more 4.0703125
▁stable 3.4921875
▁emot 1.267578125
ional 0.00885772705078125
▁state 0.7578125
▁and 1.3916015625
▁cop 5.6484375
ed 0.87939453125
▁with 0.72216796875
▁pain 1.4970703125
▁more 1.6748046875
▁manage 6.9296875
able 2.30078125
. 0.52978515625
<0x0A> 0.701171875
One 5.2578125
▁of 0.58349609375
▁the 0.0177459716796875
▁major 2.546875
▁limitations 2.732421875
▁is 3.9609375
▁the 0.52001953125
▁ins 4.75
u 0.017486572265625
fficient 0.08746337890625
ly 4.81640625
▁high 3.076171875
▁response 2.94921875
▁rate 0.133544921875
, 2.673828125
▁ 4.7109375
5 1.9619140625
7 2.01953125
% 2.068359375
▁instead 7.38671875
▁of 0.007762908935546875
▁ 0.724609375
7 1.5078125
0 1.484375
% 1.146484375
▁( 1.662109375
Fe 0.25537109375
ing 0.006519317626953125
old 0.0016603469848632812
▁et 0.006805419921875
▁al 0.0014886856079101562
., 0.006191253662109375
▁ 0.0020847320556640625
2 0.0005211830139160156
0 4.363059997558594e-05
1 0.0011539459228515625
7 0.0074310302734375
). 0.04132080078125
▁It 2.712890625
▁can 3.240234375
▁be 0.419677734375
▁fairly 8.3359375
▁explained 1.54296875
▁by 0.166259765625
▁the 0.311279296875
▁weak 8.1875
▁focus 7.1953125
▁of 0.462890625
▁respond 6.203125
ents 0.14111328125
▁who 3.478515625
▁have 4.0546875
▁overcome 7.96484375
▁severe 2.349609375
▁pain 0.470458984375
▁sens 8.484375
ations 1.09765625
▁and 1.2177734375
▁de 4.33203125
press 1.7724609375
ive 0.2037353515625
▁episodes 4.0234375
. 0.6015625
▁It 3.375
▁is 0.7841796875
▁not 2.62890625
▁clear 4.3046875
▁how 1.662109375
▁to 3.5546875
▁use 5.34375
▁these 2.95703125
▁statistics 3.60546875
, 2.560546875
▁as 1.4072265625
▁they 1.32421875
▁still 6.17578125
▁may 4.8046875
▁be 1.4150390625
▁relevant 5.28515625
▁for 1.4052734375
▁the 1.833984375
▁overall 4.4609375
▁analysis 3.00390625
. 1.107421875
